References

Alvaro, G. and R. Di Fabio, 2007. Neurokinin 1 receptor antagonists-urrent prospects. Curr. Opin. Drug Discov. Devel., 10: 613-621.
PubMed  |  Direct Link  |  

Alvillar, B.M., P. Boscan, K.R. Mama, T.H. Ferreira, J. Congdon and D.C. Twedt, 2012. Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane Minimum Alveolar Concentration (MAC) in dogs. Vet. Anaesth. Analg., 39: 201-205.
CrossRef  |  PubMed  |  Direct Link  |  

Ament, R., 1979. Origin of the ASA classification. Anesthesiology, 51: 179-179.
PubMed  |  Direct Link  |  

Benchaoui, H.A., E.M. Siedek, V.A. De La Puente-Redondo, N. Tilt, T.G. Rowan and R.G. Clemence, 2007. Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs. Vet. Rec., 161: 444-447.
CrossRef  |  PubMed  |  Direct Link  |  

Benchaoui, H.A., S.R. Cox, R.P. Schneider, J.F. Boucher and R.G. Clemence, 2007. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs. J. Vet. Pharmacol. Ther., 30: 336-344.
CrossRef  |  PubMed  |  Direct Link  |  

Boel, A.F., 2012. Ovaries and Uterus. In: Veterinary Surgery: Small Animal, 1st Edn., Tobias, K. and S. Johnston (Eds.). Elsevier Saunders, St. Louis, MO., pp: 1871-1890.

Boscan, P., E. Monnet, K. Mama, D.C. Twedt, J. Congdon and E.P. Steffey, 2011. Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs. Am. J. Vet. Res., 72: 1576-1579.
CrossRef  |  PubMed  |  Direct Link  |  

Cheryl, S.H., 2007. Surgery of the Reproductive and Genital Systems. In: Small Animal Surgery Textbook, 3rd Edn., Fossum, T.W. (Ed.). Mosby, St. Louis, MO., pp: 702-774.

Duncan, X.L., 2012. Surgical Pain: Pathophysiology, Assessment and Treatment Strategies. In: Veterinary Surgery: Small Animal, 1st Edn., Tobias, K. and S. Johnston (Eds.). Elsevier Saunders, St. Louis, MO., pp: 237-247.

Hickman, M.A., S.R. Cox, S. Mahabir, C. Miskell, J. Lin, A. Bunger and R.B. McCall, 2008. Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats. J. Vet. Pharmacol. Ther., 31: 220-229.
CrossRef  |  PubMed  |  Direct Link  |  

Hill, R., 2000. NK₁ (substance P) receptor antagonists-why are they not analgesic in humans? Trends Pharmacol. Sci., 21: 244-246.
CrossRef  |  PubMed  |  Direct Link  |  

Lembeck, F., K. Folkers and J. Donnerer, 1981. Analgesic effect of antagonists of substance P. Biochem. Biophys. Res. Commun., 103: 1318-1321.
CrossRef  |  PubMed  |  Direct Link  |  

Mantyh, P.W. and T.L. Yaksh, 2001. Sensory neurons are PARtial to pain. Nat. Med., 7: 772-773.
CrossRef  |  PubMed  |  Direct Link  |  

Otsuka, M. and K. Yoshioka, 1993. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev., 73: 229-308.
PubMed  |  Direct Link  |  

Sedlacek, H.S., D.S. Ramsey, J.F. Boucher, J.S. Eagleson, G.A. Conder and R.G. Clemence, 2008. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. J. Vet. Pharmacol. Ther., 31: 533-537.
CrossRef  |  PubMed  |  Direct Link  |